Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Sarcoma, Kaposi × Rituximab × Clear all

Sponsor

Conditions

Lymphoma 150 Leukemia, Lymphocytic, Chronic, B-Cell 138 Lymphoma, Non-Hodgkin 135 Lymphoma, Follicular 117 Lymphoma, Large B-Cell, Diffuse 114 Lymphoma, Mantle-Cell 81 Leukemia 63 Lymphoma, B-Cell, Marginal Zone 59 Waldenstrom Macroglobulinemia 44 Burkitt Lymphoma 37 Lymphoma, B-Cell 34 Precursor Cell Lymphoblastic Leukemia-Lymphoma 33 Hodgkin Disease 32 Recurrence 22 Lymphoma, Large-Cell, Immunoblastic 22 Neoplasms 15 Myelodysplastic Syndromes 15 Lymphoma, Large-Cell, Anaplastic 13 Multiple Myeloma 12 Leukemia, Myeloid, Acute 12 Hematologic Neoplasms 9 Lymphoma, T-Cell, Cutaneous 7 Lymphoma, Extranodal NK-T-Cell 7 Leukemia, Prolymphocytic 7 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7 Leukemia, Hairy Cell 7 Intraocular Lymphoma 7 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6 Myeloproliferative Disorders 6 Leukemia, Myelomonocytic, Chronic 6

Interventions

Biopsy 3 Bevacizumab 3 technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 2 Valganciclovir 2 Specimen Handling 2 Magnetic Resonance Spectroscopy 2 tocilizumab 1 pomalidomide 1 pembrolizumab 1 liposomal doxorubicin 1 emvododstat 1 efineptakin alfa 1 Zidovudine 1 Sunitinib 1 Polymerase Chain Reaction 1 Nivolumab 1 Nelfinavir 1 Maraviroc 1 Lenalidomide 1 Ipilimumab 1 Immunohistochemistry 1 HhAntag691 1 Gene Expression Profiling 1 Etoposide 1 Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination 1 CTLA-4 Antigen 1 Antiretroviral Therapy, Highly Active 1 2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡